Your browser doesn't support javascript.
loading
Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial.
Lynch, Brigid M; Nguyen, Nga H; Moore, Melissa M; Reeves, Marina M; Rosenberg, Dori E; Boyle, Terry; Milton, Shakira; Friedenreich, Christine M; Vallance, Jeff K; English, Dallas R.
Afiliação
  • Lynch BM; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Nguyen NH; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Moore MM; Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Reeves MM; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Rosenberg DE; Medical Oncology, St. Vincent's Hospital, Melbourne, Victoria, Australia.
  • Boyle T; Cancer Prevention Research Centre, School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.
  • Milton S; Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
  • Friedenreich CM; Australian Centre for Precision Health, School of Health Sciences, University of South Australia Cancer Research Institute, Adelaide, South Australia, Australia.
  • Vallance JK; Department of General Practice, Melbourne Medical School, The University of Melbourne, Victoria, Australia.
  • English DR; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada.
Cancer ; 125(16): 2856-2860, 2019 08 15.
Article em En | MEDLINE | ID: mdl-31012968
BACKGROUND: This brief report examines the maintenance of moderate to vigorous physical activity (MVPA) and sedentary behavior changes approximately 12 weeks after the delivery of the ACTIVATE Trial primary intervention (use of the Garmin Vivofit 2 activity tracker coupled with a behavioral feedback and goal-setting session and 5 telephone-delivered health coaching sessions). We also examine the efficacy of an abridged intervention (use of the Garmin Vivofit 2 only) in the waitlist control group. METHODS: A pre-post design was employed to examine the secondary aims of the ACTIVATE Trial (n = 80; mean age = 62 years). MVPA and sedentary behavior were measured using Actigraph and activPAL accelerometers after delivery of the primary intervention (T2), and again 12 weeks later (T3). Linear mixed models with random effects were used to examine within-group changes in MVPA and sitting time variables. RESULTS: After the 12-week follow-up period, women in the primary intervention group had maintained their higher levels of MVPA (change from T2 to T3 = 14 min/wk; 95% CI = -18 to 46; P = .37). However, their sitting time increased slightly, by 7 min/d (95% CI = -20 to 34; P = .58), but it did not return to its preintervention level. After receiving the Garmin Vivofit 2, the waitlist control group increased their MVPA by 33 min/wk (95% CI = 3-64; P = .03) and reduced their sitting time by 38 min/d (95% CI = -69 to -7; P = .02) over the same 12-week period. CONCLUSION: The secondary outcomes from the ACTIVATE Trial suggest that wearable technology may generate sustainable changes in MVPA and sitting time. Wearable technology alone may be sufficient to change behavior, at least in the short term.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exercício Físico / Sobreviventes de Câncer Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exercício Físico / Sobreviventes de Câncer Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália